Abiopharma

News list

Ashiya Mona 🟢 acquired 66.3K shares (1 derivative) of Shattuck Labs, Inc. (STTK) at $0.99 Transaction Date: Aug 28, 2025 | Filing ID: 193328

Full text

News bot Sept. 2, 2025, 10:36 a.m.
🔍 Ashiya Mona (Executive)

Company: Shattuck Labs, Inc. (STTK)

Report Date: 2025-08-28
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 66,300
Detailed Transactions and Holdings:
- Acquired 66,300 shares of Stock Option (Right to Buy) at $0.99 per share (Derivative)
  Date: 2025-08-28 | Code: A | Expires: 2035-08-28 | equity_swap_involved: false | shares_owned_after: 66,300.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This option represents the right to purchase a total of 66,300 shares of the Issuer's common stock, and vests in three equal annual installments on each of the first three anniversaries of August 28, 2025, subject to the Reporting Person's continued service to the Issuer.
- F2: Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments IX, LP.